Femasys has gained approval for its FemaSeed Intratubal Insemination product and two diagnostic devices from the Ministry of ...

Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and ...

Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump ...

Whether pacemakers, insulin pumps or hip replacement, Canadians may face a spike in health costs if Trump imposes a 25 per ...

Detailed price information for Ventripoint Diagnostics Ltd (VPT-X) from The Globe and Mail including charting and trades.

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

About BND Projects Inc. BND is a Canadian consulting firm based in the Greater Toronto Area and was founded by Christina Cameron. Ms. Cameron, a capital markets expert with over 25 years of experience ...

Since its launch in 2018, more than 10 million MiYOSMART ® spectacle lenses have already been purchased by parents worldwide.

In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...

The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 ...